Review
doi: 10.1124/pr.57.4.4.International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels
Affiliations
- PMID:16382098
- DOI: 10.1124/pr.57.4.4
Item in Clipboard
Review
International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels
William A Catterall et al. Pharmacol Rev.2005 Dec.
Display options
Format
Display options
Format
Abstract
The family of voltage-gated sodium channels initiates action potentials in all types of excitable cells. Nine members of the voltage-gated sodium channel family have been characterized in mammals, and a 10th member has been recognized as a related protein. These distinct sodium channels have similar structural and functional properties, but they initiate action potentials in different cell types and have distinct regulatory and pharmacological properties. This article presents the molecular relationships and physiological roles of these sodium channel proteins and provides comprehensive information on their molecular, genetic, physiological, and pharmacological properties.
Similar articles
- International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels.Catterall WA, Goldin AL, Waxman SG; International Union of Pharmacology.Catterall WA, et al.Pharmacol Rev. 2003 Dec;55(4):575-8. doi: 10.1124/pr.55.4.7.Pharmacol Rev. 2003.PMID:14657413Review.
- The pharmacology of voltage-gated sodium channels in sensory neurones.Docherty RJ, Farmer CE.Docherty RJ, et al.Handb Exp Pharmacol. 2009;(194):519-61. doi: 10.1007/978-3-540-79090-7_15.Handb Exp Pharmacol. 2009.PMID:19655117Review.
- International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels.Catterall WA, Striessnig J, Snutch TP, Perez-Reyes E; International Union of Pharmacology.Catterall WA, et al.Pharmacol Rev. 2003 Dec;55(4):579-81. doi: 10.1124/pr.55.4.8.Pharmacol Rev. 2003.PMID:14657414Review.
- ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels.Priest BT, Blumenthal KM, Smith JJ, Warren VA, Smith MM.Priest BT, et al.Toxicon. 2007 Feb;49(2):194-201. doi: 10.1016/j.toxicon.2006.09.014. Epub 2006 Sep 27.Toxicon. 2007.PMID:17087985Review.
- International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J.Catterall WA, et al.Pharmacol Rev. 2005 Dec;57(4):411-25. doi: 10.1124/pr.57.4.5.Pharmacol Rev. 2005.PMID:16382099Review.
Cited by
- Modulation of voltage-gated K+ channels by the sodium channel β1 subunit.Nguyen HM, Miyazaki H, Hoshi N, Smith BJ, Nukina N, Goldin AL, Chandy KG.Nguyen HM, et al.Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18577-82. doi: 10.1073/pnas.1209142109. Epub 2012 Oct 22.Proc Natl Acad Sci U S A. 2012.PMID:23090990Free PMC article.
- FGF13 modulates the gating properties of the cardiac sodium channel Nav1.5 in an isoform-specific manner.Yang J, Wang Z, Sinden DS, Wang X, Shan B, Yu X, Zhang H, Pitt GS, Wang C.Yang J, et al.Channels (Austin). 2016 Sep 2;10(5):410-420. doi: 10.1080/19336950.2016.1190055. Epub 2016 May 31.Channels (Austin). 2016.PMID:27246624Free PMC article.
- A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.Tabakoff B, Ren W, Vanderlinden L, Snell LD, Matheson CJ, Wang ZJ, Levinson R, Smothers CT, Woodward JJ, Honse Y, Lovinger D, Rush AM, Sather WA, Gustafson DL, Hoffman PL.Tabakoff B, et al.Eur J Pharmacol. 2016 Aug 5;784:1-14. doi: 10.1016/j.ejphar.2016.05.006. Epub 2016 May 5.Eur J Pharmacol. 2016.PMID:27158117Free PMC article.
- Tetrodotoxin (TTX) as a therapeutic agent for pain.Nieto FR, Cobos EJ, Tejada MÁ, Sánchez-Fernández C, González-Cano R, Cendán CM.Nieto FR, et al.Mar Drugs. 2012 Feb;10(2):281-305. doi: 10.3390/md10020281. Epub 2012 Jan 31.Mar Drugs. 2012.PMID:22412801Free PMC article.Review.
- A Novel Antigen Design Strategy to Isolate Single-Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models.Martina M, Banderali U, Yogi A, Arbabi Ghahroudi M, Liu H, Sulea T, Durocher Y, Hussack G, van Faassen H, Chakravarty B, Liu QY, Iqbal U, Ling B, Lessard E, Sheff J, Robotham A, Callaghan D, Moreno M, Comas T, Ly D, Stanimirovic D.Martina M, et al.Adv Sci (Weinh). 2024 Oct;11(40):e2405432. doi: 10.1002/advs.202405432. Epub 2024 Aug 29.Adv Sci (Weinh). 2024.PMID:39206821Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases